Herbas VPB

Print
EN | LT
Supplementary protection
LT - Farmacinė kompozicija, apimanti nenukleozidinį atvirkštinės transkriptazės inhibitorių
EN - PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR
SPC
(11) Number of the document C 2924034
(68) Number of the document 2924034
(21) Application number for Supplementary Protection Certificate PA 2019 507
(22) Date of filing the application 2019-04-11
(41) Date of publication of the application 2019-04-25
Date of publication of SPC 2020-10-12
(24) Date of coming into effect of SPC 2031-03-29
Applicant
(71) Merck Canada Inc., 16711 Trans-Canada Highway, Kirkland QC H9H 3L1, CA
Grantee
(73) Merck Canada Inc., 16711 Trans-Canada Highway, Kirkland QC H9H 3L1, CA
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/18/1333, 2018-11-22
Calculated date of expiry of the SPC
(94) 2033-11-26
Name of the product protected by the basic patent
(95) Doravirinas arba jo farmaciniu požiūriu priimtina druska, derinyje su lamivudinu ir tenofoviro dizoproksilio fumaratu
Legal status
SPC granted
Last update date 2021-11-25